Gianpaolo Scalia Tomba, Frida Kasteng, Annika Ersson, Sören Andersson, Emma Appelqvist, Marie Nordahl, Kari Johansen
{"title":"Modelling Impact of Different Varicella Immunisation Strategies Upon Introduction in the Swedish National Programme.","authors":"Gianpaolo Scalia Tomba, Frida Kasteng, Annika Ersson, Sören Andersson, Emma Appelqvist, Marie Nordahl, Kari Johansen","doi":"10.1111/apa.70487","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Countries with varicella immunisation programmes have seen major reductions in disease burden. While two-dose schedules are now universally adopted, dosing ages vary, and some countries initially include catch-up vaccination of older children to speed impact. This modelling study assessed three two-dose schedules in the Swedish setting (1) 12 and 18 months, (2) 18 months and 5 years, and (3) 18 months and 7 years, with and without catch-up of susceptible children based on their medical history.</p><p><strong>Methods: </strong>A deterministic, compartmental, age-structured, dynamic transmission model was used to evaluate the different strategies.</p><p><strong>Results: </strong>With coverage similar to other childhood vaccinations in Sweden (≥ 95%) but no catch-up, varicella cases are projected to decrease significantly within four years of programme start for all schedules modelled. However, a temporary rebound may occur around years 4-7 due to accumulating susceptibles before subsiding. Adding catch-up vaccination in this high-coverage setting accelerates and sustains the decline, with varicella disease burden significantly reduced within 2-3 years.</p><p><strong>Conclusion: </strong>A national childhood varicella programme in Sweden could cut transmission and disease burden within 4 years, with catch-up vaccination speeding this to a few years and lowering rebound risk. The schedule should be guided by programmatic considerations.</p>","PeriodicalId":55562,"journal":{"name":"Acta Paediatrica","volume":" ","pages":"2525-2532"},"PeriodicalIF":1.8000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13659423/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Paediatrica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apa.70487","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: Countries with varicella immunisation programmes have seen major reductions in disease burden. While two-dose schedules are now universally adopted, dosing ages vary, and some countries initially include catch-up vaccination of older children to speed impact. This modelling study assessed three two-dose schedules in the Swedish setting (1) 12 and 18 months, (2) 18 months and 5 years, and (3) 18 months and 7 years, with and without catch-up of susceptible children based on their medical history.
Methods: A deterministic, compartmental, age-structured, dynamic transmission model was used to evaluate the different strategies.
Results: With coverage similar to other childhood vaccinations in Sweden (≥ 95%) but no catch-up, varicella cases are projected to decrease significantly within four years of programme start for all schedules modelled. However, a temporary rebound may occur around years 4-7 due to accumulating susceptibles before subsiding. Adding catch-up vaccination in this high-coverage setting accelerates and sustains the decline, with varicella disease burden significantly reduced within 2-3 years.
Conclusion: A national childhood varicella programme in Sweden could cut transmission and disease burden within 4 years, with catch-up vaccination speeding this to a few years and lowering rebound risk. The schedule should be guided by programmatic considerations.
期刊介绍:
Acta Paediatrica is a peer-reviewed monthly journal at the forefront of international pediatric research. It covers both clinical and experimental research in all areas of pediatrics including:
neonatal medicine
developmental medicine
adolescent medicine
child health and environment
psychosomatic pediatrics
child health in developing countries